The article considers the possibility of decentralization of state administration in the sphere of public health by giving a special status to national medical research centers. It is indicated that such practice is present in many countries of the world aimed at accelerated development of innovations in the sphere of biomedicine, reduction of administrative barriers in the process of conducting scientific research. Foreign experience is presented, namely Spain, USA, Canada, within the framework of which a number of administrative powers are delegated to health institutes. It is proposed to expand the competence of Russian national medical research centers due to the possibility of their distribution of grant assistance to scientific organizations, normative regulation of experimental scientific research, approval of ethical examinations of innovations in the field of biomedicine.
biomedicine, innovation, national medical research center, health care, methodological support, decentralization
1. Demina M. A. Legal regulation of scientific and innovative activities of medical organizations. Actual problems of Russian law, 2018, no. 11, pp. 116–123. (In Russ.)
2. Ley 14/2007 de 3 de julio de investigación biomédica noticias juridicas. URL: https://www.boe.es/buscar/act.php?id=BOE-A-2007-12945 (accessed 14.09.2024). (In Engl.)
3. Ley 14/ 2006, de 26 de mayo, sobre técnicas de reproducción humana asistida. URL:https://noticias.juridicas.com/base_datos/Admin/l14-2006.html (accessed 14.09.2024). (In Engl.)
4. Ley 35/1988, de 22 de noviembre, sobre técnicas de reproducción asistida. URL:https://noticias.juridicas.com/base_datos/Admin/l35-1988.html (accessed 14.09.2024). (In Engl.)
5. Office for Civil Rights. URL: https://www.hhs.gov/ocr/get-help-in-other-languages/russian.html (accessed 14.09.2024). (In Engl.)
6. National Institutes of Health. URL: https://www.nih.gov/ (accessed 14.09.2024). (In Engl.)
7. Canadian Institutes of Health Research. URL: http://cihr-irsc.gc.ca/ (accessed 14.09.2024). (In Engl.)
8. Canadian Institutes of Health Research (CIHR), Updated Guidelines for Human Pluripotent Stem Cell Research, 2010. URL: http://www.cihr-irsc.gc.ca/e/42071.html (accessed 14.09.2024). (In Engl.)
9. Overview of International Human Embryonic Stem Cell Laws. URL: https://www.thenewatlantis.com/publications/appendix-e-overview-of-international-human-embryonic-stem-cell-laws (accessed 14.09.2024). (In Engl.)
10. Marchant Gary E., Pope Lynda L. The Problems with Forbidding Science. Sci Eng Ethics, 2009, 15 (3), pp. 375–394. (In Engl.)
11. Romanovskaya O. V. Constitutional Foundations of Delegation of State Powers to Entities of Private Law (on the Example of Management Companies). Lex russica (Russian Law), 2017, no. 2 (123), pp. 32–41. (In Russ.)
12. Mokhov A. A. Pharmaceutical clusters: theory, legislation, practice. Jurist, 2017, no. 10, pp. 41–46. (In Russ.)
13. Vlasenko N. A. Individualization as a pattern of development of modern Russian legislation. Journal of Russian Law, 2015, no. 12, pp. 11–17. (In Russ.)
14. Pomortsev K. I. Cluster as a legal category. Russian Law Journal, 2021, no. 6, pp. 157–163. (In Russ.)
